Treatment with the IDO inhibitor INCB024360 increased lysis of human tumor cell targets by peptide-specific CTL

Journal for ImmunoTherapy of Cancer(2015)

Cited 0|Views33
No score
Abstract
Meeting abstracts We have investigated the in vitro effects of INCB024360 on dendritic cell maturation and activation of antigen-specific T cells. INCB024360 is a novel inhibitor of indoleamine-2, 3-dioxygenase (IDO), and is currently in several ongoing clinical trials. INCB024360 effectively
More
Translated text
Key words
Pancreatic Carcinoma,Prostate Cancer Patient,Human Breast Cancer Cell Line,Kynurenine,Dendritic Cell Maturation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined